Understanding Clostridioides difficile infection over time
Part of Infections clinical trials.
This study follows people who have a Clostridioides difficile infection to learn more about how the infection progresses and affects patients. By tracking symptoms and outcomes, researchers hope to improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a new Clostridioides difficile infection, confirmed by your doctor.
- You are willing to have your health information collected for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at Clostridium difficile (C. diff) infections in babies under 2. It compares babies who have the infection with those who don't, using medical records to learn more about how it affects them.
This study looks at how fecal microbiota transplantation (a transplant of healthy gut bacteria) works for people who get C. difficile infection repeatedly. It also focuses on collecting follow-up information to better understand which patients benefit and how.
This study follows patients with Clostridioides difficile (C. diff) infection to see how their symptoms improve and when the bacteria clear from their body. It aims to better understand recovery and guide treatment.
This study is tracking patients with a confirmed C. difficile infection to understand how the body responds and how treatments work. You may be asked to do follow-up visits for up to 5 years.
This study looks at levels of C. diff toxins in stool after standard antibiotic treatment. It aims to understand how toxins change during recovery, which may help improve future treatments for C. diff infections.
This study looks at C. difficile bacteria in babies up to 2 years old. It compares babies with C. difficile infection, carriers without symptoms, and healthy babies to understand how the bacteria affects them.
Hear when a new Clostridium Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.